United States· US:25021-790_18174b35-89ba-487a-bbc5-95716b8c1274
PROCHLORPERAZINE EDISYLATE
A medicinal product containing prochlorperazine edisylate, registered in United States by Sagent Pharmaceuticals.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PROCHLORPERAZINE EDISYLATE
- Manufacturer
- Sagent Pharmaceuticals
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1125021-790-02
- ndc1125021-790-03
- ndc11250217900210 VIAL in 1 CARTON (25021-790-02) / 2 mL in 1 VIAL
- ndc11250217900325 VIAL in 1 CARTON (25021-790-03) / 2 mL in 1 VIAL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff67d2aa-9e70-4db5-9c5c-a6e29d04a16e GET /v1/drugs/ff67d2aa-9e70-4db5-9c5c-a6e29d04a16e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR; INTRAVENOUS",
"source": "ndc",
"strength": "5",
"substance": "PROCHLORPERAZINE EDISYLATE",
"productndc": "25021-790",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA214107",
"marketing_category": "ANDA"
}See everything about prochlorperazine edisylate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.